Researchers are studying patient data looking to for a correlation between low vitamin D levels and COVID-19 mortality rates and indicate a link between vitamin D deficiency and COVID-19 severity and mortality. Vitamin D is known to strengthen immunity and prevent overactive immune responses.
Fat soluble vitamins (A, D, E, K) are crucial for human health. The addition of these vitamins into foods, pharmaceuticals, supplements and topicals is challenging due to solubility, bioavailability and stability issues. There is a tremendous need to make water soluble emulsions out of these vitamins to improve the behavior in the biological system. BEEI technology provides a way to produce repeatable, homogeneous stable nano emulsions, micro emulsions, or liposomes of fat soluble vitamins. These emulsions are critical for effectively incorporating additives such as Vitamin D into products.
Pion's BEE brand high-pressure homogenization technology differentiates from other homogenizers and mixers in delivering constant and controllable energy to the process. Our technology produces homogenous smaller and stable particles which has a significant impact on rate of absorption and total bioavailability. Our equipment is known for creating emulsions and liposomes made of two immiscible liquids that are stabilized by an emulsifying agent. Specifically this equipment is used to create emulsions and liposomes with higher bioavailability and longer shelf life.
For this reason, Pion's BEE brand equipment enables vitamins such as Vitamin D to be incorporated into oil or lipids effectively improving the efficacy of vitamin D delivery. Contact us to learn more about how we can help.
1. Petre Cristian Ilie, Simina Stefanescu, Lee Smith., The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Received: 30 March 2020 / Accepted: 15 April 2020.
2. Frank H. Lau, Rinku Majumder, Radbeh Torabi, Fouad Saeg, Ryan Hoffman, JeffreyD.Cirillo, Patrick Greiffenstein, Vitamin D insufficiency is prevalent in severe COVID-19. doi: https://doi.org/10.1101/2020.04.24.20075838.